Gallus gallus isolate bGalGal1 chromosome 22, bGalGal1.mat.broiler.GRCg7b, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Gallus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028503.1.\nAssembly name: bGalGal1.mat.broiler.GRCg7b\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/01/19. The original whole-genome shotgun project has the\naccession JAENSK000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 22-JUL-2020\nAssembly Method :: TrioCanu v. 1.8; purge_dups v. 1.0.0;\n Scaff 10x v. 4.1.0; Bionano solve v.\n 3.2.1_04122018; Salsa2 HiC v. 2.2; Arrow\n polishing and gap filling v.\n SMRTLink7.0.1; Freebayes v. 1.3.1; gEVAL\n manual curation v. 2020-07-22; VGP trio\n assembly pipeline v. 1.6\nAssembly Name :: bGalGal1.mat.broiler.GRCg7b\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 102.01x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Gallus gallus Annotation Release 106\nAnnotation Version :: 106\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC112530187, transcript variant X3
uncharacterized LOC112530187, transcript variant X2
uncharacterized LOC112530187, transcript variant X1
basic proline-rich protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
translation initiation factor IF-2-like, transcript variant X2
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
translation initiation factor IF-2-like, transcript variant X1
uncharacterized LOC101750811, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC101750811, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC101750811 isoform X2
proline-rich receptor-like protein kinase PERK7 isoform X1
AP2 associated kinase 1, transcript variant X1
AP2 associated kinase 1, transcript variant X2
AP2 associated kinase 1, transcript variant X3
AP2 associated kinase 1, transcript variant X4
AP2 associated kinase 1, transcript variant X6
AP2 associated kinase 1, transcript variant X7
AP2 associated kinase 1, transcript variant X11
AP2 associated kinase 1, transcript variant X5
AP2 associated kinase 1, transcript variant X10
AP2 associated kinase 1, transcript variant X8
AP2 associated kinase 1, transcript variant X12
AP2 associated kinase 1, transcript variant X9
AP2-associated protein kinase 1 isoform X1
AP2-associated protein kinase 1 isoform X2
AP2-associated protein kinase 1 isoform X3
AP2-associated protein kinase 1 isoform X4
AP2-associated protein kinase 1 isoform X6
AP2-associated protein kinase 1 isoform X7
AP2-associated protein kinase 1 isoform X11
AP2-associated protein kinase 1 isoform X5
AP2-associated protein kinase 1 isoform X10
AP2-associated protein kinase 1 isoform X12
AP2-associated protein kinase 1 isoform X8
AP2-associated protein kinase 1 isoform X9
microRNA 6576; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
NFU1 iron-sulfur cluster scaffold; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
NFU1 iron-sulfur cluster scaffold, transcript variant X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X1
NFU1 iron-sulfur cluster scaffold, transcript variant X3
NFU1 iron-sulfur cluster scaffold, transcript variant X2
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X2
glutamine--fructose-6-phosphate transaminase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
glutamine--fructose-6-phosphate transaminase 1, transcript variant X1
glutamine--fructose-6-phosphate transaminase 1, transcript variant X3
glutamine--fructose-6-phosphate transaminase 1, transcript variant X4
glutamine--fructose-6-phosphate transaminase 1
glutamine--fructose-6-phosphate transaminase 1, transcript variant X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, and 54% coverage of the annotated genomic feature by RNAseq alignments
bone morphogenetic protein 10; Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
Rho GTPase activating protein 25; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Rho GTPase activating protein 25, transcript variant X2
Rho GTPase activating protein 25, transcript variant X1
rho GTPase-activating protein 25 isoform X1
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X4
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X3
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X1
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X9
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X8
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X7
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X6
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X5
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, transcript variant X2
phosphatidate cytidylyltransferase 2 isoform X3
phosphatidate cytidylyltransferase 2 isoform X2
phosphatidate cytidylyltransferase 2 isoform X1
phosphatidate cytidylyltransferase 2 isoform X4
proliferating cell nuclear antigen; Derived by automated computational analysis using gene prediction method: BestRefSeq.
transmembrane protein 230; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
transmembrane protein 230, transcript variant X1
propagated from UniProtKB/Swiss-Prot (Q5ZLH4.1); transmembrane region
uncharacterized LOC107054952, transcript variant X2
uncharacterized LOC107054952, transcript variant X1
uncharacterized LOC107054952, transcript variant X3
solute carrier family 23 member 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
solute carrier family 23 member 2, transcript variant X6
solute carrier family 23 member 2, transcript variant X5
solute carrier family 23 member 2, transcript variant X3
solute carrier family 23 member 2, transcript variant X7
solute carrier family 23 member 2, transcript variant X2
solute carrier family 23 member 2, transcript variant X4
solute carrier family 23 member 2, transcript variant X1
solute carrier family 23 member 2 isoform X1
Ras association domain family member 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ras association domain-containing protein 2
prion protein; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
major prion protein homolog preproprotein
dihydropyrimidinase like 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
dihydropyrimidinase like 2, transcript variant X5
dihydropyrimidinase like 2, transcript variant X3
dihydropyrimidinase like 2, transcript variant X4
dihydropyrimidinase like 2, transcript variant X2
dihydropyrimidinase like 2, transcript variant X1
dihydropyrimidinase like 2, transcript variant X7
dihydropyrimidinase like 2, transcript variant X6
dihydropyrimidinase like 2, transcript variant X8
dihydropyrimidinase like 2, transcript variant X9
dihydropyrimidinase-related protein 2 isoform X1
dihydropyrimidinase-related protein 2 isoform X2
dihydropyrimidinase-related protein 2 isoform X3
BCL2 interacting protein 3 like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like
protein phosphatase 2 regulatory subunit Balpha; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
protein phosphatase 2 regulatory subunit Balpha, transcript variant X2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X3
protein phosphatase 2 regulatory subunit Balpha, transcript variant X1
protein phosphatase 2 regulatory subunit Balpha
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
EBF transcription factor 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
EBF transcription factor 2, transcript variant X3
EBF transcription factor 2, transcript variant X1
EBF transcription factor 2, transcript variant X2
cell division cycle associated 2, transcript variant X6
cell division cycle associated 2, transcript variant X5
cell division cycle associated 2, transcript variant X1
cell division cycle associated 2, transcript variant X2
cell division cycle associated 2, transcript variant X4
cell division cycle associated 2, transcript variant X3
cell division cycle-associated protein 2
potassium channel tetramerization domain containing 9; Derived by automated computational analysis using gene prediction method: BestRefSeq.
potassium channel tetramerization domain containing 9
gonadotropin releasing hormone 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001080877.1
annotated by transcript or proteomic data
The RefSeq transcript has 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Pyrrolidone carboxylic acid. /evidence=ECO:0000269|PubMed:7050119; propagated from UniProtKB/Swiss-Prot (P37042.1); pyrrolidone-carboxylic-acid site
Glycine amide. /evidence=ECO:0000269|PubMed:7050119; propagated from UniProtKB/Swiss-Prot (P37042.1); amidation site
dedicator of cytokinesis 5, transcript variant X4
dedicator of cytokinesis 5, transcript variant X3
dedicator of cytokinesis 5, transcript variant X2
dedicator of cytokinesis 5, transcript variant X1
dedicator of cytokinesis protein 5 isoform X2
dedicator of cytokinesis protein 5 isoform X1
dedicator of cytokinesis protein 5 isoform X3
uncharacterized LOC107054948, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 long SRA reads, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC107054948, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 long SRA reads, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neurofilament, light polypeptide, transcript variant X1
neurofilament, light polypeptide, transcript variant X2
neurofilament light polypeptide isoform X1
neurofilament light polypeptide isoform X2
neurofilament, medium polypeptide; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Head
N-acetylserine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P16053.2); acetylation site
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
O-linked (GlcNAc) threonine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P16053.2); glycosylation site
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Coil 1A
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Linker 1
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Coil 1B
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Linker 12
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Coil 2A
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Linker 2
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Coil 2B
propagated from UniProtKB/Swiss-Prot (P16053.2); Region: Tail
ADAM like decysin 1, transcript variant X2
ADAM like decysin 1, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 28 isoform X2
disintegrin and metalloproteinase domain-containing protein 28 isoform X1
NK2 homeobox 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_205137.1
The RefSeq transcript has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_990468.1
The RefSeq protein has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
solute carrier family 25 (mitochondrial iron transporter), member 37, transcript variant X1
solute carrier family 25 (mitochondrial iron transporter), member 37, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X4
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X5
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X6
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
ectonucleoside triphosphate diphosphohydrolase 4 isoform X3
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X4
ectonucleoside triphosphate diphosphohydrolase 4 isoform X5
lysyl oxidase like 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
lysyl oxidase like 2, transcript variant X1
R3H and coiled-coil domain-containing protein 1
charged multivesicular body protein 7; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
charged multivesicular body protein 7, transcript variant X1
charged multivesicular body protein 7, transcript variant X2
propagated from UniProtKB/Swiss-Prot (Q5ZJB7.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
tumor necrosis factor receptor superfamily, member 10b; Derived by automated computational analysis using gene prediction method: BestRefSeq.
tumor necrosis factor receptor superfamily, member 10b
similar to RNA sequence, mRNA (same species):RefSeq:NM_204115.3
The RefSeq transcript has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
tumor necrosis factor receptor superfamily member 10B precursor
Rho-related BTB domain containing 2, transcript variant X2
Rho-related BTB domain containing 2, transcript variant X1
Rho-related BTB domain containing 2, transcript variant X3
rho-related BTB domain-containing protein 2 isoform X1
rho-related BTB domain-containing protein 2 isoform X2
phosphatidylethanolamine binding protein 4
phosphatidylethanolamine-binding protein 4
uncharacterized LOC121107409, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: early growth response protein 3
bridging integrator 3, transcript variant X11
bridging integrator 3, transcript variant X8
bridging integrator 3, transcript variant X14
bridging integrator 3, transcript variant X6
bridging integrator 3, transcript variant X9
bridging integrator 3, transcript variant X1
bridging integrator 3, transcript variant X13
bridging integrator 3, transcript variant X7
bridging integrator 3, transcript variant X10
bridging integrator 3, transcript variant X5
bridging integrator 3, transcript variant X3
bridging integrator 3, transcript variant X12
bridging integrator 3, transcript variant X4
bridging integrator 3, transcript variant X15
bridging integrator 3, transcript variant X16
bridging integrator 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC121107411, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 98% coverage of the annotated genomic feature by RNAseq alignments
WAS/WASL-interacting protein family member 1-like
serine/threonine-protein phosphatase 2B catalytic subunit, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X4
polysaccharide biosynthesis domain containing 1
exportin 7; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
docking protein 2, transcript variant X1
docking protein 2, transcript variant X2
docking protein 2, transcript variant X3
uncharacterized LOC101749127, transcript variant X36
uncharacterized LOC101749127, transcript variant X1
uncharacterized LOC101749127, transcript variant X34
uncharacterized LOC101749127, transcript variant X50
uncharacterized LOC101749127, transcript variant X45
uncharacterized LOC101749127, transcript variant X30
uncharacterized LOC101749127, transcript variant X16
uncharacterized LOC101749127, transcript variant X8
uncharacterized protein LOC101749127 isoform X1
uncharacterized LOC101749127, transcript variant X41
uncharacterized LOC101749127, transcript variant X20
uncharacterized LOC101749127, transcript variant X39
uncharacterized LOC101749127, transcript variant X38
uncharacterized LOC101749127, transcript variant X13
uncharacterized LOC101749127, transcript variant X24
uncharacterized LOC101749127, transcript variant X44
uncharacterized LOC101749127, transcript variant X47
uncharacterized LOC101749127, transcript variant X19
uncharacterized LOC101749127, transcript variant X40
uncharacterized LOC101749127, transcript variant X11
uncharacterized LOC101749127, transcript variant X43
uncharacterized LOC101749127, transcript variant X9
uncharacterized LOC101749127, transcript variant X35
uncharacterized LOC101749127, transcript variant X28
uncharacterized LOC101749127, transcript variant X4
uncharacterized LOC101749127, transcript variant X21
uncharacterized LOC101749127, transcript variant X14
uncharacterized LOC101749127, transcript variant X42
uncharacterized LOC101749127, transcript variant X6
uncharacterized LOC101749127, transcript variant X25
uncharacterized LOC101749127, transcript variant X18
uncharacterized LOC101749127, transcript variant X2
uncharacterized LOC101749127, transcript variant X12
uncharacterized LOC101749127, transcript variant X7
uncharacterized LOC101749127, transcript variant X32
uncharacterized LOC101749127, transcript variant X22
uncharacterized LOC101749127, transcript variant X5
uncharacterized LOC101749127, transcript variant X17
uncharacterized LOC101749127, transcript variant X15
uncharacterized LOC101749127, transcript variant X23
uncharacterized LOC101749127, transcript variant X37
uncharacterized LOC101749127, transcript variant X49
uncharacterized LOC101749127, transcript variant X3
uncharacterized LOC101749127, transcript variant X31
uncharacterized LOC101749127, transcript variant X33
uncharacterized LOC101749127, transcript variant X26
uncharacterized LOC101749127, transcript variant X10
uncharacterized LOC101749127, transcript variant X29
uncharacterized LOC101749127, transcript variant X27
uncharacterized LOC101749127, transcript variant X48
uncharacterized LOC101749127, transcript variant X46
GDNF family receptor alpha 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_205101.1
The RefSeq transcript has 9 substitutions, 14 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_990432.1
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (O13157.1); glycosylation site
leucine zipper putative tumor suppressor 1
ATPase H+ transporting V1 subunit B2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
TELO2 interacting protein 2, transcript variant X2
TELO2 interacting protein 2, transcript variant X12
TELO2 interacting protein 2, transcript variant X11
TELO2 interacting protein 2, transcript variant X8
TELO2 interacting protein 2, transcript variant X7
TELO2 interacting protein 2, transcript variant X10
TELO2 interacting protein 2, transcript variant X9
TELO2 interacting protein 2, transcript variant X4
TELO2 interacting protein 2, transcript variant X3
TELO2 interacting protein 2, transcript variant X6
TELO2 interacting protein 2, transcript variant X5
TELO2 interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
ring finger protein 122, transcript variant X2
ring finger protein 122, transcript variant X1
dual specificity phosphatase 26 (putative)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 11 long SRA reads, and 75% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC101749927, transcript variant X4
uncharacterized LOC101749927, transcript variant X3
uncharacterized LOC101749927, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC101749927, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unc-5 netrin receptor D, transcript variant X1
unc-5 netrin receptor D, transcript variant X3
unc-5 netrin receptor D, transcript variant X2
unc-5 netrin receptor D, transcript variant X4
uncharacterized LOC107054966, transcript variant X2
uncharacterized LOC107054966, transcript variant X1
potassium calcium-activated channel subfamily U member 1, transcript variant X1
potassium channel subfamily U member 1 isoform X1
potassium calcium-activated channel subfamily U member 1, transcript variant X2
potassium channel subfamily U member 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC112530177, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC112530177, transcript variant X4
uncharacterized LOC112530177, transcript variant X2
uncharacterized LOC112530177, transcript variant X1
uncharacterized protein LOC112530177 isoform X2
uncharacterized protein LOC112530177 isoform X1
zinc finger protein 703, transcript variant X4
zinc finger protein 703, transcript variant X2
zinc finger protein 703, transcript variant X3
zinc finger protein 703, transcript variant X1
proline synthetase cotranscribed homolog (bacterial), transcript variant X1
proline synthetase cotranscribed homolog (bacterial), transcript variant X2
pyridoxal phosphate homeostasis protein isoform X1
pyridoxal phosphate homeostasis protein isoform X2
adhesion G protein-coupled receptor A2, transcript variant X2
adhesion G protein-coupled receptor A2, transcript variant X3
adhesion G protein-coupled receptor A2 isoform X2
adhesion G protein-coupled receptor A2, transcript variant X1
adhesion G protein-coupled receptor A2 isoform X1
adhesion G protein-coupled receptor A2, transcript variant X4
adhesion G protein-coupled receptor A2 isoform X3
BRF2 RNA polymerase III transcription initiation factor subunit
transcription factor IIIB 50 kDa subunit
RAB11 family interacting protein 1, transcript variant X2
RAB11 family interacting protein 1, transcript variant X1
rab11 family-interacting protein 1 isoform X2
rab11 family-interacting protein 1 isoform X1
prolactin releasing hormone receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
prolactin releasing hormone receptor, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001127171.1
prolactin releasing hormone receptor isoform X1
nucleoplasmin-like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
nucleoplasmin-like, transcript variant X1
adrenoceptor beta 3, transcript variant X1
adrenoceptor beta 3, transcript variant X2
eukaryotic translation initiation factor 4E binding protein 1
eukaryotic translation initiation factor 4E-binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 long SRA reads, 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ASH2 like histone lysine methyltransferase complex subunit; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ASH2 like histone lysine methyltransferase complex subunit, transcript variant X1
ASH2 like histone lysine methyltransferase complex subunit
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1
set1/Ash2 histone methyltransferase complex subunit ASH2
steroidogenic acute regulatory protein; Derived by automated computational analysis using gene prediction method: BestRefSeq.
steroidogenic acute regulatory protein, mitochondrial precursor
Mitochondrion. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q9DG09.1)
LSM1 homolog, mRNA degradation associated, transcript variant X2
LSM1 homolog, mRNA degradation associated, transcript variant X1
U6 snRNA-associated Sm-like protein LSm1 isoform X2
U6 snRNA-associated Sm-like protein LSm1 isoform X1
BAG family molecular chaperone regulator 4
DDHD domain containing 2, transcript variant X1
DDHD domain containing 2, transcript variant X2
DDHD domain containing 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DDHD domain containing 2, transcript variant X3
DDHD domain containing 2, transcript variant X6
DDHD domain containing 2, transcript variant X4
DDHD domain containing 2, transcript variant X5
Wolf-Hirschhorn syndrome candidate 1-like 1, transcript variant X1
Wolf-Hirschhorn syndrome candidate 1-like 1, transcript variant X5
Wolf-Hirschhorn syndrome candidate 1-like 1, transcript variant X4
Wolf-Hirschhorn syndrome candidate 1-like 1, transcript variant X2
Wolf-Hirschhorn syndrome candidate 1-like 1, transcript variant X3
histone-lysine N-methyltransferase NSD3 isoform X4
histone-lysine N-methyltransferase NSD3 isoform X3
histone-lysine N-methyltransferase NSD3 isoform X2
histone-lysine N-methyltransferase NSD3 isoform X1
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X1
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X2
LETM1 domain-containing protein LETM2, mitochondrial isoform X1
LETM1 domain-containing protein LETM2, mitochondrial isoform X2
fibroblast growth factor receptor 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
fibroblast growth factor receptor 1, transcript variant X7
fibroblast growth factor receptor 1, transcript variant X6
fibroblast growth factor receptor 1, transcript variant X3
fibroblast growth factor receptor 1, transcript variant X2
fibroblast growth factor receptor 1, transcript variant X1
fibroblast growth factor receptor 1, transcript variant X5
fibroblast growth factor receptor 1, transcript variant X4
fibroblast growth factor receptor 1 isoform X6
fibroblast growth factor receptor 1 isoform X5
fibroblast growth factor receptor 1 isoform X4
fibroblast growth factor receptor 1 precursor
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P21804.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P21804.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (P21804.1); transmembrane region
Phosphotyrosine, by autocatalysis. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P21804.1); phosphorylation site
fibroblast growth factor receptor 1 isoform X3
fibroblast growth factor receptor 1 isoform X2
fibroblast growth factor receptor 1 isoform X1
transforming acidic coiled-coil containing protein 1, transcript variant X10
transforming acidic coiled-coil containing protein 1, transcript variant X9
transforming acidic coiled-coil containing protein 1, transcript variant X7
transforming acidic coiled-coil containing protein 1, transcript variant X8
transforming acidic coiled-coil containing protein 1, transcript variant X1
transforming acidic coiled-coil containing protein 1, transcript variant X2
transforming acidic coiled-coil containing protein 1, transcript variant X4
transforming acidic coiled-coil containing protein 1, transcript variant X13
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil-containing protein 1 isoform X8
transforming acidic coiled-coil containing protein 1, transcript variant X12
transforming acidic coiled-coil containing protein 1, transcript variant X3
transforming acidic coiled-coil containing protein 1, transcript variant X5
transforming acidic coiled-coil containing protein 1, transcript variant X14
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming acidic coiled-coil-containing protein 1 isoform X5
transforming acidic coiled-coil-containing protein 1 isoform X9
transforming acidic coiled-coil containing protein 1, transcript variant X11
transforming acidic coiled-coil containing protein 1, transcript variant X6
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X7
pleckstrin homology domain containing A2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
pleckstrin homology domain containing A2, transcript variant X2
pleckstrin homology domain containing A2, transcript variant X4
pleckstrin homology domain containing A2, transcript variant X1
pleckstrin homology domain containing A2
pleckstrin homology domain containing A2, transcript variant X3
pleckstrin homology domain-containing family A member 2 isoform X1
pleckstrin homology domain-containing family A member 2 isoform X2
pleckstrin homology domain-containing family A member 2
ADAM metallopeptidase domain 9; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ADAM metallopeptidase domain 9, transcript variant X1
ADAM metallopeptidase domain 9, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 9 isoform X1
disintegrin and metalloproteinase domain-containing protein 9 isoform X2
disintegrin and metalloproteinase domain-containing protein 9 precursor
ADAM metallopeptidase domain 32, transcript variant X1
ADAM metallopeptidase domain 32, transcript variant X3
ADAM metallopeptidase domain 32, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 32-like isoform X1
disintegrin and metalloproteinase domain-containing protein 32-like isoform X3
disintegrin and metalloproteinase domain-containing protein 32-like isoform X2
ADAM metallopeptidase domain 32-like 1, transcript variant X1
ADAM metallopeptidase domain 32-like 1, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 18 isoform X1
disintegrin and metalloproteinase domain-containing protein 18 isoform X2
disintegrin and metalloproteinase domain-containing protein 32
indoleamine 2,3-dioxygenase 2, transcript variant X1
indoleamine 2,3-dioxygenase 2, transcript variant X2
indoleamine 2,3-dioxygenase 2, transcript variant X3
indoleamine 2,3-dioxygenase 2 isoform X2
indoleamine 2,3-dioxygenase 2 isoform X1
indoleamine 2,3-dioxygenase 2 isoform X3
transcriptional and immune response regulator
zinc finger matrin-type 4, transcript variant X2
zinc finger matrin-type 4, transcript variant X9
zinc finger matrin-type 4, transcript variant X7
zinc finger matrin-type 4, transcript variant X10
zinc finger matrin-type 4, transcript variant X8
zinc finger matrin-type 4, transcript variant X5
zinc finger matrin-type 4, transcript variant X4
zinc finger matrin-type 4, transcript variant X6
zinc finger matrin-type 4, transcript variant X3
zinc finger matrin-type 4, transcript variant X1
zinc finger matrin-type 4, transcript variant X11
secreted frizzled related protein 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
secreted frizzled-related protein 1 precursor
golgin A7; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
GINS4-PPP1RL readthrough; Derived by automated computational analysis using gene prediction method: BestRefSeq.
GINS complex subunit 4 (Sld5 homolog); Derived by automated computational analysis using gene prediction method: BestRefSeq.
DNA replication complex GINS protein SLD5
protein phosphatase 1 regulatory subunit like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
protein phosphatase 1 regulatory subunit like
Protein phosphatase 1 regulatory subunit
glycerol-3-phosphate acyltransferase 4, transcript variant X1
glycerol-3-phosphate acyltransferase 4, transcript variant X2
microRNA 2188; Derived by automated computational analysis using gene prediction method: BestRefSeq.
lysine acetyltransferase 6A, transcript variant X1
lysine acetyltransferase 6A, transcript variant X2
histone acetyltransferase KAT6A isoform X1
histone acetyltransferase KAT6A isoform X2
adaptor related protein complex 3 mu 2 subunit, transcript variant X1
adaptor related protein complex 3 mu 2 subunit, transcript variant X4
adaptor related protein complex 3 mu 2 subunit, transcript variant X2
adaptor related protein complex 3 mu 2 subunit, transcript variant X3
plasminogen activator, tissue type, transcript variant X1
plasminogen activator, tissue type, transcript variant X4
plasminogen activator, tissue type, transcript variant X2
plasminogen activator, tissue type, transcript variant X3
tissue-type plasminogen activator isoform X1
tissue-type plasminogen activator isoform X2
plasminogen activator, tissue type, transcript variant X5
plasminogen activator, tissue type, transcript variant X6
tissue-type plasminogen activator isoform X3
tissue-type plasminogen activator isoform X4
inhibitor of nuclear factor kappa B kinase subunit beta; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta
inhibitor of nuclear factor kappa-B kinase subunit beta
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X3
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
voltage dependent anion channel 3, transcript variant X2
voltage dependent anion channel 3, transcript variant X1
voltage dependent anion channel 3, transcript variant X9
voltage dependent anion channel 3, transcript variant X6
voltage dependent anion channel 3, transcript variant X3
voltage dependent anion channel 3, transcript variant X12
voltage dependent anion channel 3, transcript variant X11
voltage dependent anion channel 3, transcript variant X10
voltage dependent anion channel 3, transcript variant X7
voltage dependent anion channel 3, transcript variant X4
voltage dependent anion channel 3, transcript variant X14
voltage dependent anion channel 3, transcript variant X13
voltage dependent anion channel 3, transcript variant X8
voltage dependent anion channel 3, transcript variant X5
voltage dependent anion channel 3, transcript variant X15
voltage-dependent anion-selective channel protein 3 isoform X6
voltage-dependent anion-selective channel protein 3 isoform X5
voltage-dependent anion-selective channel protein 3 isoform X4
voltage-dependent anion-selective channel protein 3 isoform X3
voltage-dependent anion-selective channel protein 3 isoform X2
voltage-dependent anion-selective channel protein 3 isoform X1
DNA polymerase beta, transcript variant X2
DNA polymerase beta, transcript variant X3
DNA polymerase beta, transcript variant X1
transmembrane protein 127, transcript variant X1
cytosolic iron-sulfur assembly component 1
probable cytosolic iron-sulfur protein assembly protein CIAO1
small nuclear ribonucleoprotein U5 subunit 200
LOW QUALITY PROTEIN: U5 small nuclear ribonucleoprotein 200 kDa helicase
family with sequence similarity 178, member B
ankyrin repeat domain-containing protein 39
cyclin and CBS domain divalent metal cation transport mediator 4, transcript variant X2
cyclin and CBS domain divalent metal cation transport mediator 4, transcript variant X3
cyclin and CBS domain divalent metal cation transport mediator 4, transcript variant X1
lectin, mannose binding 2 like, transcript variant X3
lectin, mannose binding 2 like, transcript variant X1
lectin, mannose binding 2 like, transcript variant X2
lectin, mannose binding 2 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 26 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
KAT8 regulatory NSL complex subunit 3, transcript variant X1
KAT8 regulatory NSL complex subunit 3, transcript variant X7
KAT8 regulatory NSL complex subunit 3, transcript variant X2
KAT8 regulatory NSL complex subunit 3, transcript variant X4
KAT8 regulatory NSL complex subunit 3, transcript variant X9
KAT8 regulatory NSL complex subunit 3, transcript variant X3
KAT8 regulatory NSL complex subunit 3, transcript variant X8
KAT8 regulatory NSL complex subunit 3, transcript variant X5
KAT8 regulatory NSL complex subunit 3, transcript variant X10
KAT8 regulatory NSL complex subunit 3, transcript variant X11
KAT8 regulatory NSL complex subunit 3, transcript variant X6
KAT8 regulatory NSL complex subunit 3 isoform X1
KAT8 regulatory NSL complex subunit 3 isoform X2
KAT8 regulatory NSL complex subunit 3 isoform X4
KAT8 regulatory NSL complex subunit 3 isoform X3
KAT8 regulatory NSL complex subunit 3 isoform X5
KAT8 regulatory NSL complex subunit 3 isoform X7
KAT8 regulatory NSL complex subunit 3 isoform X9
KAT8 regulatory NSL complex subunit 3 isoform X8
KAT8 regulatory NSL complex subunit 3 isoform X10
KAT8 regulatory NSL complex subunit 3 isoform X11
KAT8 regulatory NSL complex subunit 3 isoform X6
AT rich interactive domain 5A (MRF1-like)
AT-rich interactive domain-containing protein 5A isoform X1
uncharacterized LOC121107419, transcript variant X1
uncharacterized LOC121107419, transcript variant X2
uncharacterized LOC121107419, transcript variant X3
uncharacterized protein LOC121107419 isoform X1
basic proline-rich protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC121107421, transcript variant X2
uncharacterized LOC121107421, transcript variant X1
basic proline-rich protein-like isoform X1
uncharacterized LOC124417355, transcript variant X1
uncharacterized LOC124417355, transcript variant X2
serine/threonine-protein kinase LATS1-like, transcript variant X1
serine/threonine-protein kinase LATS1-like, transcript variant X2
RNA/RNP complex-1-interacting phosphatase-like, transcript variant X1
RNA/RNP complex-1-interacting phosphatase-like, transcript variant X2
RNA/RNP complex-1-interacting phosphatase
STAM binding protein, transcript variant X2
STAM binding protein, transcript variant X1
STAM binding protein, transcript variant X4
STAM binding protein, transcript variant X3
actin, gamma 2, smooth muscle, enteric; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-acetylcysteine, in intermediate form. /evidence=ECO:0000250|UniProtKB:P62737; propagated from UniProtKB/Swiss-Prot (P63270.1); acetylation site
Actin, gamma-enteric smooth muscle. /evidence=ECO:0000250|UniProtKB:P63267. /id=PRO_0000442956
propagated from UniProtKB/Swiss-Prot (P63270.1)
N-acetylglutamate, in Actin, gamma-enteric smooth muscle. /evidence=ECO:0000250|UniProtKB:P63267; propagated from UniProtKB/Swiss-Prot (P63270.1); acetylation site
Tele-methylhistidine. /evidence=ECO:0000269|Ref.3, ECO:0007744|PDB:3W3D; propagated from UniProtKB/Swiss-Prot (P63270.1); methylation site
N6-methyllysine. /evidence=ECO:0000250|UniProtKB:P68133; propagated from UniProtKB/Swiss-Prot (P63270.1); methylation site
uncharacterized LOC107054976, transcript variant X2
uncharacterized LOC107054976, transcript variant X1
LOW QUALITY PROTEIN: methylcytosine dioxygenase TET3
bolA family member 3, transcript variant X1
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase, transcript variant X1
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial
Mitochondrion. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q5ZKA5.1)
propagated from UniProtKB/Swiss-Prot (Q5ZKA5.1); Region: Substrate binding. /evidence=ECO:0000250|UniProtKB:P13995
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X1
solute carrier family 4 member 5, transcript variant X1
solute carrier family 4 member 5, transcript variant X2
solute carrier family 4 member 5, transcript variant X3
electrogenic sodium bicarbonate cotransporter 4 isoform X1
electrogenic sodium bicarbonate cotransporter 4 isoform X2
electrogenic sodium bicarbonate cotransporter 4 isoform X3
tetraspanin 15 like, transcript variant X1
tetraspanin 15 like, transcript variant X4
tetraspanin 15 like, transcript variant X2
tetraspanin 15 like, transcript variant X3
tachykinin receptor 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
non-SMC condensin I complex subunit H; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
non-SMC condensin I complex subunit H, transcript variant X1
non-SMC condensin I complex subunit H, transcript variant X2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001257332.2
The RefSeq transcript has 4 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001244261.1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 12 long SRA reads, 12 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
H2A.Z variant histone 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
H2A.Z variant histone 2, transcript variant X1
propagated from UniProtKB/Swiss-Prot (P02272.2); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
N6-acetyllysine. /evidence=ECO:0000269|PubMed:16204459; propagated from UniProtKB/Swiss-Prot (P02272.2); acetylation site
uncharacterized LOC124417356, transcript variant X1
transcriptional activator protein Pur-beta-like
transcriptional activator protein Pur-beta
cytochrome c oxidase subunit 5B, mitochondrial
potassium voltage-gated channel interacting protein 3, transcript variant X1
potassium voltage-gated channel interacting protein 3, transcript variant X4
potassium voltage-gated channel interacting protein 3, transcript variant X2
potassium voltage-gated channel interacting protein 3, transcript variant X3
potassium voltage-gated channel interacting protein 3, transcript variant X5
uncharacterized LOC121107423, transcript variant X1
uncharacterized LOC121107423, transcript variant X2
germ cell-less, spermatogenesis associated 1, transcript variant X1
germ cell-less, spermatogenesis associated 1, transcript variant X2
germ cell-less protein-like 1 isoform X1
germ cell-less protein-like 1 isoform X2
germ cell-less, spermatogenesis associated 1, transcript variant X3
germ cell-less, spermatogenesis associated 1, transcript variant X4
germ cell-less, spermatogenesis associated 1, transcript variant X5
germ cell-less, spermatogenesis associated 1, transcript variant X6
germ cell-less protein-like 1 isoform X3
hexokinase 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
isoform 1 is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 2 is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
factor in the germline alpha-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
glutamine-rich protein 2-like, transcript variant X3
glutamine-rich protein 2-like, transcript variant X1
glutamine-rich protein 2-like, transcript variant X2
glutamine-rich protein 2-like isoform X2
glutamine-rich protein 2-like isoform X1
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein
MAX dimerization protein 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001039310.1
The RefSeq transcript has 18 substitutions, 3 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
MAX dimerization protein 1, transcript variant X1
C2orf42 homolog; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
uncharacterized protein C2orf42 homolog isoform X4
uncharacterized protein C2orf42 homolog isoform X3
uncharacterized protein C2orf42 homolog isoform X2
uncharacterized protein C2orf42 homolog isoform X1
uncharacterized protein C2orf42 homolog isoform X6
uncharacterized protein C2orf42 homolog isoform X5
TIA1 cytotoxic granule associated RNA binding protein; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X2
TIA1 cytotoxic granule associated RNA binding protein
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X3
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X1
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X6
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X20
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X21
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X14
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X17
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X11
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X16
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X13
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X7
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X4
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X15
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X12
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X8
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X19
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X18
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X5
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X10
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X9
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X22
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
small nuclear ribonucleoprotein polypeptide G pseudogene 15; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
small nuclear ribonucleoprotein polypeptide G pseudogene 15, transcript variant X1
small nuclear ribonucleoprotein polypeptide G pseudogene 15, transcript variant X2
small nuclear ribonucleoprotein polypeptide G pseudogene 15
family with sequence similarity 136 member A; Derived by automated computational analysis using gene prediction method: BestRefSeq.
family with sequence similarity 136 member A
transforming growth factor alpha; Derived by automated computational analysis using gene prediction method: BestRefSeq.
protransforming growth factor alpha precursor
uncharacterized LOC107054988, transcript variant X6
uncharacterized LOC107054988, transcript variant X7
uncharacterized LOC107054988, transcript variant X11
uncharacterized LOC107054988, transcript variant X9
uncharacterized LOC107054988, transcript variant X3
uncharacterized LOC107054988, transcript variant X2
uncharacterized LOC107054988, transcript variant X12
uncharacterized LOC107054988, transcript variant X4
uncharacterized LOC107054988, transcript variant X8
uncharacterized LOC107054988, transcript variant X5
uncharacterized LOC107054988, transcript variant X1
uncharacterized LOC107054988, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat transmembrane neuronal 4
leucine-rich repeat transmembrane neuronal protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC121107430, transcript variant X2
uncharacterized LOC121107430, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC121107430 isoform X2
uncharacterized protein LOC121107430 isoform X1
uncharacterized LOC121107410, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 82% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC121107410 isoform X1
uncharacterized LOC121107434, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC121107434, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121107434, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC121107434, transcript variant X1
uncharacterized protein LOC121107434 isoform X3
uncharacterized protein LOC121107434 isoform X1
uncharacterized protein LOC121107434 isoform X2
solute carrier family 20 member 1, transcript variant X1
solute carrier family 20 member 1, transcript variant X2
sodium-dependent phosphate transporter 1
5'-nucleotidase domain containing 4, transcript variant X1
5'-nucleotidase domain containing 4, transcript variant X2
cytosolic purine 5'-nucleotidase isoform X1
cytosolic purine 5'-nucleotidase isoform X2
cytoskeleton associated protein 2 like, transcript variant X2
cytoskeleton associated protein 2 like, transcript variant X1
cytoskeleton associated protein 2 like, transcript variant X3
cytoskeleton-associated protein 2-like isoform X1
cytoskeleton-associated protein 2-like isoform X3
cytoskeleton-associated protein 2-like isoform X2
uncharacterized LOC107054991, transcript variant X1
interleukin 1, beta; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
interleukin 1, beta, transcript variant X1
oxoglutarate dehydrogenase; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
oxoglutarate dehydrogenase, transcript variant X2
oxoglutarate dehydrogenase, transcript variant X1
oxoglutarate dehydrogenase, transcript variant X3
2-oxoglutarate dehydrogenase, mitochondrial isoform X2
2-oxoglutarate dehydrogenase, mitochondrial
2-oxoglutarate dehydrogenase, mitochondrial isoform X1
2-oxoglutarate dehydrogenase, mitochondrial isoform X3
oxoglutarate dehydrogenase, transcript variant X4
2-oxoglutarate dehydrogenase, mitochondrial isoform X4
zinc finger MIZ domain-containing protein 2-like, transcript variant X3
zinc finger MIZ domain-containing protein 2-like, transcript variant X1
zinc finger MIZ domain-containing protein 2-like, transcript variant X2
zinc finger MIZ domain-containing protein 2 isoform X1
zinc finger MIZ domain-containing protein 2 isoform X2
zinc finger MIZ domain-containing protein 2 isoform X3
microRNA mir-12247-1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
peptidylprolyl isomerase A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
peptidylprolyl isomerase A, transcript variant X1
peptidyl-prolyl cis-trans isomerase A isoform X1
NudC domain containing 3, transcript variant X2
nudC domain-containing protein 3 isoform X2
NudC domain containing 3, transcript variant X1
nudC domain-containing protein 3 isoform X1
NudC domain containing 3, transcript variant X3
NudC domain containing 3, transcript variant X4
calcium/calmodulin dependent protein kinase II beta; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
calcium/calmodulin dependent protein kinase II beta, transcript variant X1
calcium/calmodulin dependent protein kinase II beta, transcript variant X2
calcium/calmodulin dependent protein kinase II beta, transcript variant X8
calcium/calmodulin dependent protein kinase II beta
calcium/calmodulin dependent protein kinase II beta, transcript variant X3
calcium/calmodulin dependent protein kinase II beta, transcript variant X9
calcium/calmodulin dependent protein kinase II beta, transcript variant X4
calcium/calmodulin dependent protein kinase II beta, transcript variant X6
calcium/calmodulin dependent protein kinase II beta, transcript variant X5
calcium/calmodulin dependent protein kinase II beta, transcript variant X7
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X2
calcium/calmodulin-dependent protein kinase type II subunit beta
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X3
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X5
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X7
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X8
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X9
YKT6 v-SNARE homolog (S. cerevisiae); Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
YKT6 v-SNARE homolog (S. cerevisiae), transcript variant X1
granulysin; Derived by automated computational analysis using gene prediction method: BestRefSeq.
DNA polymerase delta 2, accessory subunit, transcript variant X2
DNA polymerase delta 2, accessory subunit, transcript variant X3
DNA polymerase delta 2, accessory subunit, transcript variant X5
DNA polymerase delta 2, accessory subunit, transcript variant X4
DNA polymerase delta 2, accessory subunit, transcript variant X1
DNA polymerase delta subunit 2 isoform X1
DNA polymerase delta subunit 2 isoform X2
capping actin protein, gelsolin like, transcript variant X3
capping actin protein, gelsolin like, transcript variant X2
capping actin protein, gelsolin like, transcript variant X1
transcription factor 7 like 1, transcript variant X2
transcription factor 7-like 1 isoform X2
transcription factor 7 like 1, transcript variant X1
transcription factor 7 like 1, transcript variant X3
transcription factor 7 like 1, transcript variant X4
transcription factor 7-like 1 isoform X4
transcription factor 7-like 1 isoform X1
transcription factor 7-like 1 isoform X3
trans-Golgi network integral membrane protein 2
caspase 14, apoptosis-related cysteine peptidase; Derived by automated computational analysis using gene prediction method: BestRefSeq.
caspase 14, apoptosis-related cysteine peptidase, transcript variant 3
caspase 14, apoptosis-related cysteine peptidase, transcript variant 1
caspase 14, apoptosis-related cysteine peptidase, transcript variant 2
isoform 2 is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ELMO domain containing 3, transcript variant X6
ELMO domain containing 3, transcript variant X10
ELMO domain containing 3, transcript variant X3
ELMO domain containing 3, transcript variant X4
ELMO domain containing 3, transcript variant X5
ELMO domain containing 3, transcript variant X2
ELMO domain containing 3, transcript variant X1
ELMO domain containing 3, transcript variant X8
ELMO domain containing 3, transcript variant X9
ELMO domain containing 3, transcript variant X7
ELMO domain containing 3, transcript variant X13
ELMO domain containing 3, transcript variant X14
ELMO domain containing 3, transcript variant X15
ELMO domain containing 3, transcript variant X12
ELMO domain containing 3, transcript variant X11
ELMO domain containing 3, transcript variant X21
ELMO domain containing 3, transcript variant X16
ELMO domain containing 3, transcript variant X17
ELMO domain containing 3, transcript variant X22
ELMO domain containing 3, transcript variant X19
ELMO domain containing 3, transcript variant X20
ELMO domain containing 3, transcript variant X18
ELMO domain containing 3, transcript variant X26
ELMO domain containing 3, transcript variant X25
ELMO domain containing 3, transcript variant X24
ELMO domain containing 3, transcript variant X23
ELMO domain-containing protein 3 isoform X4
ELMO domain-containing protein 3 isoform X8
ELMO domain-containing protein 3 isoform X3
ELMO domain-containing protein 3 isoform X7
ELMO domain-containing protein 3 isoform X5
ELMO domain-containing protein 3 isoform X1
ELMO domain-containing protein 3 isoform X2
ELMO domain-containing protein 3 isoform X9
ELMO domain-containing protein 3 isoform X10
ELMO domain-containing protein 3 isoform X6
ELMO domain-containing protein 3 isoform X11
adrenoceptor alpha 2B, transcript variant X1
LOW QUALITY PROTEIN: alpha-2B adrenergic receptor isoform X1
glycerol-3-phosphate acyltransferase 2, mitochondrial
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X1
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X1
uncharacterized LOC121107438, transcript variant X1
uncharacterized LOC121107438, transcript variant X2
uncharacterized protein LOC121107438 isoform X1
uncharacterized protein LOC121107438 isoform X2
uncharacterized LOC121107428, transcript variant X1
uncharacterized LOC121107428, transcript variant X2
uncharacterized protein LOC121107428 isoform X1
uncharacterized LOC107049416, transcript variant X5
uncharacterized LOC107049416, transcript variant X7
uncharacterized LOC107049416, transcript variant X2
uncharacterized LOC107049416, transcript variant X6
uncharacterized LOC107049416, transcript variant X1
uncharacterized LOC107049416, transcript variant X3
uncharacterized LOC107049416, transcript variant X4